Marché mondial des aliments médicaux pour les erreurs innées du métabolisme – Tendances et prévisions de l’industrie jusqu’en 2031

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché mondial des aliments médicaux pour les erreurs innées du métabolisme – Tendances et prévisions de l’industrie jusqu’en 2031

  • Pharmaceutical
  • Publish Reports
  • Apr 2024
  • Global
  • 350 Pages
  • Nombre de tableaux : 849
  • Nombre de figures : 31

Global Medical Foods For Inborn Errors Of Metabolism Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
2024 –2031
Diagram Taille du marché (année de référence)
USD 2,477.81 Million
Diagram Taille du marché (année de prévision)
USD 7,998.77 Million
Diagram TCAC
%
Diagram Principaux acteurs du marché
  • Nutricia
  • Abbott
  • Baxter
  • Nestlé Health Science
  • Meiji Holdings Co.

>Marché mondial des aliments médicaux pour les erreurs innées du métabolisme, par produits (acides aminés, aliments à faible teneur en protéines, glytactine avec préparation pour nourrissons modifiée par des acides aminés GMP avec du fer, préparation pour nourrissons à faible teneur en calcium/sans vitamine D avec du fer et autres), maladies (phénylcétonurie (PKU), ryrosinémie de types I et II, maladie des urines au sirop d'érable (MSUD), homocystinurie, acidémie glutarique de type I, troubles du cycle de l'urée, acidémie méthylmalonique, acidémie isovalérique, aciduries organiques, maladie rénale, université propionique, troubles du métabolisme de la leucine et autres), groupe d'âge (nourrissons, sevrage, adolescents et adultes), formes (poudre, liquide, comprimés, gels et autres), emballage (boîte, pot, paquets, bouteille et autres), canal de distribution (pharmacie de détail, pharmacie d'hôpital, pharmacie en ligne, pharmacie et autres) - Tendances et prévisions de l’industrie jusqu’en 2031.

Marché des aliments médicaux pour les erreurs innées du métabolisme

Analyse et taille du marché des aliments médicaux pour les erreurs innées du métabolisme

L'augmentation du nombre d'incidences d'erreurs innées du métabolisme (IEM) et la préférence pour les compléments alimentaires par rapport à la thérapie de remplacement enzymatique (ERT) devraient stimuler la croissance du marché. Le manque de mécanismes de remboursement pour ces aliments médicaux et leur coût élevé pourraient freiner la croissance du marché.

Data Bridge Market Research analyse que le marché mondial des aliments médicaux pour les erreurs innées du métabolisme devrait croître à un TCAC de 14,1 % au cours de la période de prévision de 2023 à 2031 et devrait atteindre 7 998,77 millions USD d'ici 2031 contre 2 477,81 millions USD en 2023.

Marché des aliments médicaux pour les erreurs innées du métabolismeMarché des aliments médicaux pour les erreurs innées du métabolisme

Le rapport sur le marché mondial des aliments médicaux pour les erreurs innées du métabolisme fournit des détails sur la part de marché, les nouveaux développements et l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste. Notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Rapport métrique

Détails

Période de prévision

2023 à 2031

Année de base

2022

Années historiques

2021 (personnalisable de 2015 à 2020)

Unités quantitatives

Chiffre d'affaires en millions USD

Segments couverts

Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, and Others), Diseases (Phenylketonuria (PKU), Ryrosinemia Types I And II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Academia, Disorders Of Leucine Metabolism, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Forms (Powder, Liquid, Tablets , Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Drugs Store, and Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Finland, Denmark, Sweden, Norway, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, New Zealand, Vietnam, Philippines, Taiwan, rest of Asia-Pacific Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, Bahrain, U.A.E., Kuwait, Qatar, Egypt, Oman, and rest of Middle East and Africa

Market Players Covered

Nutricia, Abbott, Baxter, Nestlé Health Science, Meiji Holdings Co., Ltd., Hexagon Nutrition Ltd, Kate Farms, Primus Pharmaceuticals, inc., Promin, Ajinomoto Cambrooke, Inc., Galen Limited, Piam Farmaceutici S.P.A., Orpharma Pty Ltd., PKU-Mdmil.com, B. Braun SE, Pristine Organics Pvt Ltd., Mead Johnson & Company, LLC., EBM Medical, Biovencer Healthcare Pvt Ltd, and Solace Nutrition, among others

Market Definition

Inborn Errors of Metabolism (IEM) are a group of disorders in which the body fails to convert food into energy. Due to mutations in genes, there is less or no production of specific enzymes, these enzymes are responsible for breaking down certain substances. This breakdown leads to the accumulation of some toxic substances and results in severe complications. To treat these disorders, the concerned patients are given specific diets which are also known as medical foods under the supervision of physicians. For instance, Phenylketonuria (PKU) is a disease in which there is an accumulation of an amino acid which is known as phenylalanine. This can cause intellectual disability, seizures, and many other mental disorders. To treat this, they are given IEM diets such as Phenylketonuria (PKU)-1 manufactured by Pristine Organics Pvt Ltd.

Global Medical Foods for Inborn Errors of Metabolism Market Dynamics

Drivers

  • Rising Incidences of Inborn Errors of Metabolism (IEM)

Advanced diagnostic methods play an essential role in the increasing acceptance of IEM. In the past, these disorders were often misdiagnosed or overlooked due to limited information and diagnostic tools. However, advances in medical technology and genetic testing have changed our ability to accurately diagnose IEM. Advanced technologies such as next-generation sequencing and biochemical analysis allow healthcare professionals to identify specific genetic mutations or abnormalities in metabolic pathways associated with these disorders. This improved diagnostic accuracy has contributed to the increased incidence of IEM. For instance, advances in next-generation sequencing technology have made it possible to identify rare IEM variants that were previously difficult to locate. This enabled a more accurate and comprehensive diagnosis of these disorders.

  • Rising Preference for Dietary Supplements Over Enzyme Replacement Therapy (ERT)

The rising preference for dietary supplements over Enzyme Replacement Therapy (ERT) in the treatment of IEM may be due to several factors. First, dietary supplements offer a non-invasive and convenient approach to treatment. Unlike ERT, which often involves an injection or infusion, supplements can be taken orally, making them more attractive to patients who want a less invasive option. In addition, food supplements provide comprehensive nutritional support, as they contain various nutrients, cofactors, and substrates necessary for optimal metabolism. This broader spectrum of support addresses several metabolic deficits associated with specific IEM, which can lead to more effective management of the condition.

The increased popularity of nutritional supplements has led to a growing demand for specialty medical foods that meet the unique nutritional needs of IEM patients. This expanded the size of the market and led manufacturers to develop a wider range of products to meet this demand. In addition, the preference for dietary supplements encouraged R&D to improve the composition and effectiveness of medical foods, which led to the use of new and better alternatives. Thus, the rising preference for dietary supplements over ERT in the management of IEM is expected to drive market growth.

Marché des aliments médicaux pour les erreurs innées du métabolisme

Opportunities

  • Government Initiatives and Programs for Creating Awareness About Inborn Errors of Metabolism

Governments around the world have recognized the importance of raising awareness about IEM and have implemented various initiatives and programs to address this need. These initiatives aim to educate healthcare professionals, individuals and families affected by IEM, and the general public. Here are some government initiatives and programs to raise awareness of IEM. Government initiatives and programs aimed at increasing awareness of IEM act as market opportunities, driving demand for diagnostic tools, therapeutic procedures, and specialty products. These initiatives also promote R&D, facilitate market expansion through international collaboration and provide funding and support to companies in the field. Thus, government initiative and programs for creating awareness about IEM is expected to provide an opportunity for market growth.

Restraint/Challenge

  • High Cost of Medical Foods

The high cost of medical foods is due to many factors that affect the cost of their production, development, and distribution. Firstly, special medical foods require extensive R&D. Manufacturers invest in scientific research and clinical trials to find the optimal combination of nutrients, bioactive compounds, and therapeutic agents to treat specific health conditions. This study involves the expertise of nutritionist’s food and health professionals, which increases the total cost. The high cost of medical foods is a market constraint because it limits affordability and market reach. Expensive price tags put these specialty nutritional products out of reach for many people. Thus, the high cost of medical foods is expected to restraint market growth.

Recent Developments

  • In October 2023, Nestlé Health Science and Amwell announced a collaboration to help health organizations improve patients’ overall health through innovative digital solutions focused on nutrition. Together the companies are developing a portfolio of novel solutions to help improve clinical and financial outcomes. This will enhance the brand image for both the companies
  • In March 2021, Meiji Co., Ltd. launched formula milk in tablet format under Danone's Aptamil brand in the UK. The tablets, featuring pre-measured tabs, aim to provide convenience for parents. Production began in Wexford, Ireland, combining Meiji's technology with Danone's recipes. Danone plans to expand the product to other European countries starting in 2022. Meiji aims to increase overseas sales to 10% by FY 2026

Global Medical Foods for Inborn Errors of Metabolism Market Scope

The global medical foods for inborn errors of metabolism market is segmented into six notable segments based on products, diseases, age group, forms, packaging, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Products

  • Amino Acid
  • Low Protein Food
  • Glytactin avec préparation pour nourrissons à base d'acides aminés modifiés GMP et de fer
  • Préparation pour nourrissons à faible teneur en calcium et sans vitamine D avec fer
  • Autres

Sur la base des produits, le marché mondial des aliments médicaux pour les erreurs innées du métabolisme est segmenté en acides aminés, glytactine avec préparations pour nourrissons modifiées aux acides aminés GMP avec fer, préparations pour nourrissons à faible teneur en calcium/sans vitamine D avec fer, aliments à faible teneur en protéines et autres. 

Maladies

  • Phénylcétonurie (PCU)
  • Tyrosinémie de types I et II
  • Maladie urinaire à odeur de sirop d'érable (MSUD)
  • Homocystinurie
  • Acidémie glutarique de type I
  • Troubles du cycle de l'urée
  • Acidémie méthylmalonique
  • Acidémie isovalérique
  • Aciduries organiques
  • Maladie rénale
  • Acidémie propionique
  • Troubles du métabolisme de la leucine
  • Autres

Sur la base des maladies, le marché mondial des aliments médicaux pour les erreurs innées du métabolisme est segmenté en phénylcétonurie (PKU), tyrosinémie de types I et II, maladie des urines au sirop d'érable (MSUD), homocystinurie, acidémie glutarique de type I, troubles du cycle de l'urée, acidémie méthylmalonique, acidémie isovalérique, aciduries organiques, maladie rénale, académie propionique, troubles du métabolisme de la leucine et autres.

Groupe d'âge

  • Nourrissons
  • Sevrages
  • Adolescent
  • Adultes

Sur la base du groupe d’âge, le marché mondial des aliments médicaux pour les erreurs innées du métabolisme est segmenté en nourrissons, sevrage, adolescents et adultes.

Formulaires

  • Poudre
  • Liquide
  • Tablettes
  • Gels
  • Autres

Sur la base des formes, le marché mondial des aliments médicaux pour les erreurs innées du métabolisme est segmenté en poudre, liquide, comprimés, gels et autres.

Conditionnement

  • Peut
  • Paquets
  • Bouteille
  • Pot
  • Autres

Sur la base de l'emballage, le marché mondial des aliments médicaux pour les erreurs innées du métabolisme est segmenté en boîtes, pots, paquets, bouteilles et autres.

Canal de distribution

  • Pharmacie de l'hôpital
  • Pharmacie de détail
  • Pharmacies
  • Pharmacie en ligne
  • Autres

Sur la base du canal de distribution, le marché mondial des aliments médicaux pour les erreurs innées du métabolisme est segmenté en pharmacie de détail, pharmacie hospitalière, pharmacie en ligne, pharmacie en ligne et autres.

Marché des aliments médicaux pour les erreurs innées du métabolisme

Analyse/perspectives régionales du marché mondial des aliments médicaux pour les erreurs innées du métabolisme

Le marché mondial des aliments médicaux pour les erreurs innées du métabolisme est segmenté en six segments notables en fonction des produits, des maladies, de la tranche d’âge, des formes, de l’emballage et du canal de distribution.

Les pays du marché mondial des aliments médicaux pour les erreurs innées du métabolisme sont les suivants : États-Unis, Canada, Mexique, Allemagne, France, Royaume-Uni, Italie, Espagne, Russie, Turquie, Belgique, Pays-Bas, Suisse, Pologne, Finlande, Danemark, Suède, Norvège, reste de l'Europe, Japon, Chine, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Nouvelle-Zélande, Vietnam, Philippines, Taïwan, reste de l'Asie-Pacifique, Brésil, Argentine, reste de l'Amérique du Sud, Afrique du Sud, Arabie saoudite, Bahreïn, Émirats arabes unis, Koweït, Qatar, Égypte, Oman et reste du Moyen-Orient et de l'Afrique.

L'Amérique du Nord devrait dominer le marché mondial des aliments médicaux pour les maladies génétiques rares en raison de son infrastructure de soins de santé de pointe, de ses efforts de recherche intensifs, de sa surveillance réglementaire rigoureuse, de la sensibilisation accrue du public à ces maladies, de l'accès généralisé à une couverture d'assurance complète et de politiques gouvernementales proactives. Les États-Unis devraient dominer la région Amérique du Nord en raison des fabricants qui fournissent des solutions innovantes pour la gestion des maladies génétiques rares et, par conséquent, les revenus sont fortement générés dans cette région. La Chine devrait dominer la région Asie-Pacifique en raison de son avantage concurrentiel en termes d'efficacité de production et de rentabilité. L'Allemagne devrait dominer la région Europe, car de nombreux produits améliorés et avancés sont lancés sur ce marché par les fabricants.

La section pays du rapport fournit également des facteurs individuels d'impact sur le marché et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. L'analyse des points de données en aval et en amont de la chaîne de valeur, l'analyse des tendances techniques des cinq forces de Porter et les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.   

Marché des aliments médicaux pour les erreurs innées du métabolisme

Analyse du paysage concurrentiel et des parts de marché mondiales des aliments médicaux pour les erreurs innées du métabolisme

Le paysage concurrentiel du marché mondial des aliments médicaux pour les erreurs innées du métabolisme fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial des aliments médicaux pour les erreurs innées du métabolisme.

Français Certains des principaux acteurs opérant sur le marché mondial des aliments médicaux pour les erreurs innées du métabolisme sont Nutricia, Abbott, Baxter, Nestlé Health Science, Meiji Holdings Co., Ltd., Hexagon Nutrition Ltd, Kate Farms, Primus Pharmaceuticals, inc., Promin, Ajinomoto Cambrooke, Inc., Galen Limited, Piam Farmaceutici SPA, Orpharma Pty Ltd., PKU-Mdmil.com, B. Braun SE, Pristine Organics Pvt Ltd., Mead Johnson & Company, LLC., EBM Medical, Biovencer Healthcare Pvt Ltd et Solace Nutrition, entre autres.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 DBMR MARKET POSITION GRID

2.8 SECONDARY SOURCES

2.9 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 EPIDEMIOLOGY

4.1.1 PREVALENCE OF INBORN ERRORS OF METABOLISM

4.1.2 NEW-BORN SCREENING PROGRAMS

4.1.3 GENETIC HETEROGENEITY

4.1.4 IMPACT ON HEALTH

4.1.5 CLINICAL IMPAC

4.1.6 TREATMENT AND MANAGEMENT

4.2 PESTLE ANALYSIS

4.2.1 POLITICAL FACTORS

4.2.2 ECONOMIC FACTORS

4.2.3 SOCIAL FACTORS

4.2.4 TECHNOLOGICAL FACTORS

4.2.5 ENVIRONMENTAL FACTORS

4.2.6 LEGAL FACTORS

4.3 PORTER’S FIVE FORCES

4.3.1 THREAT OF NEW ENTRANTS

4.3.2 THREAT OF SUBSTITUTES

4.3.3 BARGAINING POWER OF BUYERS

4.3.4 BARGAINING POWER OF SUPPLIERS

4.3.5 COMPETITIVE RIVALRY

4.4 INDUSTRY INSIGHTS

4.4.1 DEMOGRAPHIC TRENDS

4.4.2 KEY PRICING STRATEGIES

4.4.3 KEY PATIENT ENROLLMENT STRATEGIES

4.5 PATENT ANALYSIS

4.6 PIPELINE ANALYSIS

4.6.1 RESEARCH AND DEVELOPMENT

4.6.2 CLINICAL TRIALS

4.6.3 REGULATORY APPROVAL

4.6.4 MANUFACTURING AND PRODUCTION

4.6.5 COMMERCIALIZATION AND MARKET ACCESS

4.6.6 DISTRIBUTION AND SUPPLY CHAIN MANAGEMENT

4.6.7 POST-MARKET SURVEILLANCE AND MONITORING

4.7 REGULATION COVERAGE

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISING INCIDENCES OF INBORN ERRORS OF METABOLISM (IEM)

5.1.2 RISING PREFERENCE FOR DIETARY SUPPLEMENTS OVER ENZYME REPLACEMENT THERAPY (ERT)

5.1.3 INCREASE IN THE NUMBER OF NEW-BORN SCREENING PROCEDURES

5.1.4 INCREASING SPENDING ON MEDICAL FOOD PRODUCTS

5.2 RESTRAINTS

5.2.1 HIGH COST OF MEDICAL FOODS

5.2.2 STRINGENT REGULATIONS FOR MEDICAL FOODS

5.3 OPPORTUNITIES

5.3.1 GOVERNMENT INITIATIVES AND PROGRAMS FOR CREATING AWARENESS ABOUT INBORN ERRORS OF METABOLISM

5.3.2 INCREASING COLLABORATIONS AND PARTNERSHIPS IN THE MARKET

5.3.3 EXPANSION OF MEDICAL FOODS IN EMERGING MARKETS

5.4 CHALLENGES

5.4.1 POOR ACCESSIBILITY OF MEDICAL FOODS

5.4.2 ALTERNATIVE TREATMENT APPROACHES FOR INBORN ERRORS OF METABOLISM

6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS

6.1 OVERVIEW

6.2 AMINO ACID

6.2.1 AMINO ACID, BY PRODUCTS

6.2.1.1 amino acid mixtures, BY products

6.2.1.2 phenylade, BY products

6.2.1.1 single amino acids, BY products

6.3 LOW PROTEIN FOOD

6.3.1 LOW PROTEIN FOOD, BY PRODUCTS

6.4 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON

6.4.1 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON, BY FLAVORS

6.4.2 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON, BY USAGES

6.5 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON

6.5.1 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON, BY PRODUCTS

6.6 OTHERS

7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES

7.1 OVERVIEW

7.2 PHENYLKETONURIA (PKU)

7.2.1 PHENYLKETONURIA (PKU), BY DISEASES

7.3 TYROSINEMIA TYPES I AND II

7.4 MAPLE SYRUP URINE DISEASE (MSUD)

7.4.1 MAPLE SYRUP URINE DISEASE (MSUD), BY DISEASES

7.5 HOMOCYSTINURIA

7.5.1 GLUTARIC ACIDEMIA TYPE I

7.6 UREA CYCLE DISORDERS

7.6.1 UREA CYCLE DISORDERS, BY DISEASES

7.7 METHYLMALONIC ACIDEMIA

7.7.1 ISOVALERIC ACIDEMIA

7.8 ORGANIC ACIDURIAS

7.9 RENAL DISEASE

7.1 PROPIONIC ACIDEMIA

7.11 DISORDERS OF LEUCINE METABOLISM

7.12 OTHERS

8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP

8.1 OVERVIEW

8.2 INFANTS

8.3 WEANING

8.4 ADOLESCENT

8.5 ADULTS

9 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS

9.1 OVERVIEW

9.2 POWDER

9.3 LIQUID

9.4 TABLETS

9.5 GELS

9.6 OTHERS

10 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING

10.1 OVERVIEW

10.2 CAN

10.3 PACKETS

10.4 BOTTLE

10.5 JAR

10.6 OTHERS

11 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 HOSPITAL PHARMACY

11.3 RETAIL PHARMACY

11.4 DRUG STORES

11.5 ONLINE PHARMACY

11.6 OTHERS

12 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION

12.1 OVERVIEW

12.2 NORTH AMERICA

12.2.1 U S

12.2.2 CANADA

12.2.3 MEXICO

12.3 EUROPE

12.3.1 GERMANY

12.3.2 FRANCE

12.3.3 U K

12.3.4 ITALY

12.3.5 SPAIN

12.3.6 SWITZERLAND

12.3.7 NETHERLAND

12.3.8 BELGIUM

12.3.9 DENMARK

12.3.10 RUSSIA

12.3.11 SWEDEN

12.3.12 TURKEY

12.3.13 POLAND

12.3.14 FINLAND

12.3.15 REST OF EUROPE

12.4 ASIA-PACIFIC

12.4.1 CHINA

12.4.2 JAPAN

12.4.3 INDIA

12.4.4 AUSTRALIA

12.4.5 SOUTH KOREA

12.4.6 THAILAND

12.4.7 SINGAPORE

12.4.8 INDONESIA

12.4.9 MALASIA

12.4.10 NEW ZEALAND

12.4.11 VIETNAM

12.4.12 PHILIPPINES

12.4.13 TAIWAN

12.4.14 REST OF ASIA-PACIFIC

12.5 SOUTH AMERICA

12.5.1 BRAZIL

12.5.2 ARGENTINA

12.5.3 REST OF SOUTH AMERICA

12.6 MIDDLE EAST AND AFRICA

12.6.1 SOUTH AFRICA

12.6.2 SAUDI ARABIA

12.6.3 BAHRAIN

12.6.4 UNITED ARAB EMIRATES

12.6.5 KUWAIT

12.6.6 QATAR

12.6.7 EGYPT

12.6.8 OMAN

12.6.9 REST OF MIDDLE EAST AND AFRICA

13 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: GLOBAL

13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3 COMPANY SHARE ANALYSIS: EUROPE

13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 ABBOTT

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 NESTLÉ HEALTH SCIENCE (A SUBSIDIARY OF NESTLÉ)

15.2.1 COMPANY SNAPSHOT

15.2.2 COMPANY SHARE ANALYSIS

15.2.3 PRODUCT PORTFOLIO

15.2.4 RECENT DEVELOPMENTS

15.3 MEIJI HOLDINGS CO., LTD.

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 BAXTER

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 PRISTINE ORGANICS PVT LTD.

15.5.1 COMPANY SNAPSHOT

15.5.2 COMPANY SHARE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 AJINOMOTO CAMBROOKE, INC. (A SUBSIDIARY OF AJINOMOTO CO., INC.)

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 B.BRAUN SE

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 BIOVENCER HEALTHCARE PVT LTD

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 EBM MEDICAL

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 GALEN LIMITED

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 HEXAGON NUTRITION LTD.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 KATE FARMS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 MEAD JOHNSON & COMPANY, LLC. (A SUBSIDIARY OF RECKITT BENCKISER GROUP PLC.)

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 NUTRICIA (A SUBSIDIARY OF DANONE)

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 ORPHARMA PTY LTD.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 PIAM FARMACEUTICI S.P.A

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 PKU-MDMIL

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 PRIMUS PHARMACEUTICALS, INC.

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENT

15.19 PROMIN

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.2 SOLACE NUTRITION

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

Liste des tableaux

TABLE 1 COSTS OF MEDICAL FOODS USED IN INBORN ERRORS OF METABOLISM (IEMS)

TABLE 2 PATENT ANALYSIS

TABLE 3 REGULATORY COVERAGE

TABLE 4 COSTS OF MEDICAL FOODS

TABLE 5 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 6 GLOBAL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 7 GLOBAL AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 8 GLOBAL AMINO ACIDS MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 9 GLOBAL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 10 GLOBAL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 11 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 12 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 13 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 14 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 15 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 16 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 17 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 18 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 19 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 20 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 21 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 22 GLOBAL TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 23 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 24 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 25 GLOBAL HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 26 GLOBAL GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 27 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 28 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 29 GLOBAL METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 30 GLOBAL ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 31 GLOBAL ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 32 GLOBAL RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 33 GLOBAL PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 34 GLOBAL DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 35 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 36 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 37 GLOBAL INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 38 GLOBAL WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 39 GLOBAL ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 40 GLOBAL ADULTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 41 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 42 GLOBAL POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 43 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 44 GLOBAL TABLETS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 45 GLOBAL GELS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 46 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 47 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 48 GLOBAL CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 49 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 50 GLOBAL BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 51 GLOBAL JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 52 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 53 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 54 GLOBAL HOSPITAL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 55 GLOBAL RETAIL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 56 GLOBAL DRUG STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 57 GLOBAL ONLINE PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 58 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 59 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)

TABLE 60 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)

TABLE 61 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 62 NORTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 63 NORTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 64 NORTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 65 NORTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 66 NORTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 67 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 68 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 69 NORTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 70 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 71 NORTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 72 NORTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 73 NORTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 74 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 75 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 76 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 77 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 78 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 79 U.S. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 80 U.S. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 81 U.S. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 82 U.S. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 83 U.S. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 84 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 85 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 86 U.S. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 87 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 88 U.S. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 89 U.S. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 90 U.S. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 91 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 92 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 93 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 94 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 95 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 96 CANADA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 97 CANADA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 98 CANADA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 99 CANADA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 100 CANADA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 101 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 102 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 103 CANADA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 104 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 105 CANADA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 106 CANADA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 107 CANADA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 108 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 109 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 110 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 111 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 112 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 113 MEXICO AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 114 MEXICO AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 115 MEXICO PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 116 MEXICO SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 117 MEXICO LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 118 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 119 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 120 MEXICO LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 121 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 122 MEXICO PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 123 MEXICO MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 124 MEXICO UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 125 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 126 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 127 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 128 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 129 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)

TABLE 130 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 131 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 132 EUROPE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 133 EUROPE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 134 EUROPE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 135 EUROPE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 136 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 137 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 138 EUROPE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 139 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 140 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 141 EUROPE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 142 EUROPE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 143 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 144 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 145 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 146 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 147 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 148 GERMANY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 149 GERMANY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 150 GERMANY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 151 GERMANY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 152 GERMANY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 153 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 154 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 155 GERMANY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 156 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 157 GERMANY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 158 GERMANY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 159 GERMANY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 160 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 161 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 162 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 163 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 164 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 165 FRANCE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 166 FRANCE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 167 FRANCE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 168 FRANCE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 169 FRANCE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 170 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 171 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 172 FRANCE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 173 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 174 FRANCE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 175 FRANCE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 176 FRANCE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 177 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 178 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 179 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 180 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 181 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 182 U.K. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 183 U.K. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 184 U.K. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 185 U.K. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 186 U.K. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 187 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 188 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 189 U.K. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 190 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 191 U.K. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 192 U.K. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 193 U.K. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 194 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 195 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 196 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 197 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 198 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 199 ITALY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 200 ITALY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 201 ITALY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 202 ITALY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 203 ITALY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 204 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 205 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 206 ITALY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 207 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 208 ITALY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 209 ITALY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 210 ITALY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 211 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 212 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 213 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 214 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 215 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 216 SPAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 217 SPAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 218 SPAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 219 SPAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 220 SPAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 221 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 222 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 223 SPAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 224 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 225 SPAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 226 SPAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 227 SPAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 228 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 229 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 230 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 231 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 232 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 233 SWITZERLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 234 SWITZERLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 235 SWITZERLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 236 SWITZERLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 237 SWITZERLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 238 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 239 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 240 SWITZERLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 241 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 242 SWITZERLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 243 SWITZERLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 244 SWITZERLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 245 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 246 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 247 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 248 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 249 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 250 NETHERLANDS AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 251 NETHERLANDS AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 252 NETHERLANDS PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 253 NETHERLANDS SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 254 NETHERLANDS LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 255 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 256 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 257 NETHERLANDS LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 258 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 259 NETHERLANDS PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 260 NETHERLANDS MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 261 NETHERLANDS UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 262 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 263 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 264 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 265 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 266 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 267 BELGIUM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 268 BELGIUM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 269 BELGIUM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 270 BELGIUM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 271 BELGIUM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 272 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 273 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 274 BELGIUM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 275 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 276 BELGIUM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 277 BELGIUM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 278 BELGIUM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 279 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 280 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 281 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 282 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 283 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 284 DENMARK AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 285 DENMARK AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 286 DENMARK PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 287 DENMARK SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 288 DENMARK LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 289 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 290 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 291 DENMARK LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 292 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 293 DENMARK PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 294 DENMARK MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 295 DENMARK UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 296 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 297 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 298 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 299 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 300 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 301 RUSSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 302 RUSSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 303 RUSSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 304 RUSSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 305 RUSSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 306 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 307 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 308 RUSSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 309 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 310 RUSSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 311 RUSSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 312 RUSSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 313 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 314 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 315 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 316 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 317 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 318 SWEDEN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 319 SWEDEN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 320 SWEDEN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 321 SWEDEN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 322 SWEDEN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 323 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 324 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 325 SWEDEN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 326 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 327 SWEDEN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 328 SWEDEN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 329 SWEDEN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 330 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 331 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 332 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 333 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 334 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 335 TURKEY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 336 TURKEY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 337 TURKEY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 338 TURKEY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 339 TURKEY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 340 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 341 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 342 TURKEY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 343 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 344 TURKEY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 345 TURKEY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 346 TURKEY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 347 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 348 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 349 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 350 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 351 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 352 POLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 353 POLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 354 POLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 355 POLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 356 POLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 357 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 358 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 359 POLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 360 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 361 POLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 362 POLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 363 POLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 364 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 365 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 366 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 367 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 368 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 369 FINLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 370 FINLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 371 FINLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 372 FINLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 373 FINLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 374 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 375 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 376 FINLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 377 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 378 FINLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 379 FINLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 380 FINLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 381 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 382 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 383 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 384 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 385 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 386 NORWAY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 387 NORWAY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 388 NORWAY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 389 NORWAY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 390 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 391 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 392 NORWAY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 393 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 394 NORWAY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 395 NORWAY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 396 NORWAY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 397 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 398 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 399 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 400 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 401 REST OF EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 402 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)

TABLE 403 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 404 ASIA-PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 405 ASIA-PACIFIC AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 406 ASIA-PACIFIC PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 407 ASIA-PACIFIC SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 408 ASIA-PACIFIC LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 409 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 410 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 411 ASIA-PACIFIC LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 412 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 413 ASIA-PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 414 ASIA-PACIFIC MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 415 ASIA-PACIFIC UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 416 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 417 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 418 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 419 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 420 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 421 CHINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 422 CHINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 423 CHINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 424 CHINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 425 CHINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 426 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 427 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 428 CHINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 429 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 430 CHINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 431 CHINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 432 CHINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 433 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 434 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 435 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 436 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 437 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 438 JAPAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 439 JAPAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 440 JAPAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 441 JAPAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 442 JAPAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 443 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 444 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 445 JAPAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 446 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 447 JAPAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 448 JAPAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 449 JAPAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 450 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 451 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 452 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 453 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 454 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 455 INDIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 456 INDIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 457 INDIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 458 INDIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 459 INDIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 460 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 461 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 462 INDIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 463 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 464 INDIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 465 INDIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 466 INDIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 467 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 468 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 469 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 470 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 471 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 472 AUSTRALIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 473 AUSTRALIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 474 AUSTRALIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 475 AUSTRALIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 476 AUSTRALIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 477 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 478 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 479 AUSTRALIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 480 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 481 AUSTRALIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 482 AUSTRALIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 483 AUSTRALIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 484 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 485 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 486 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 487 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 488 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 489 SOUTH KOREA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 490 SOUTH KOREA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 491 SOUTH KOREA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 492 SOUTH KOREA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 493 SOUTH KOREA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 494 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 495 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 496 SOUTH KOREA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 497 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 498 SOUTH KOREA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 499 SOUTH KOREA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 500 SOUTH KOREA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 501 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 502 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 503 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 504 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 505 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 506 THAILAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 507 THAILAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 508 THAILAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 509 THAILAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 510 THAILAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 511 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 512 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 513 THAILAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 514 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 515 THAILAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 516 THAILAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 517 THAILAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 518 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 519 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 520 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 521 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 522 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 523 SINGAPORE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 524 SINGAPORE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 525 SINGAPORE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 526 SINGAPORE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 527 SINGAPORE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 528 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 529 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 530 SINGAPORE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 531 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 532 SINGAPORE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 533 SINGAPORE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 534 SINGAPORE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 535 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 536 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 537 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 538 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 539 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 540 INDONESIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 541 INDONESIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 542 INDONESIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 543 INDONESIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 544 INDONESIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 545 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 546 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 547 INDONESIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 548 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 549 INDONESIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 550 INDONESIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 551 INDONESIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 552 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 553 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 554 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 555 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 556 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 557 MALAYSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 558 MALAYSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 559 MALAYSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 560 MALAYSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 561 MALAYSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 562 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 563 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 564 MALAYSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 565 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 566 MALAYSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 567 MALAYSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 568 MALAYSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 569 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 570 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 571 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 572 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 573 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 574 NEW ZEALAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 575 NEW ZEALAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 576 NEW ZEALAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 577 NEW ZEALAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 578 NEW ZEALAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 579 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 580 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 581 NEW ZEALAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 582 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 583 NEW ZEALAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 584 NEW ZEALAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 585 NEW ZEALAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 586 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 587 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 588 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 589 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 590 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 591 VIETNAM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 592 VIETNAM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 593 VIETNAM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 594 VIETNAM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 595 VIETNAM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 596 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 597 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 598 VIETNAM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 599 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 600 VIETNAM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 601 VIETNAM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 602 VIETNAM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 603 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 604 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 605 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 606 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 607 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 608 PHILIPPINES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 609 PHILIPPINES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 610 PHILIPPINES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 611 PHILIPPINES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 612 PHILIPPINES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 613 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 614 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 615 PHILIPPINES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 616 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 617 PHILIPPINES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 618 PHILIPPINES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 619 PHILIPPINES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 620 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 621 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 622 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 623 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 624 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 625 TAIWAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 626 TAIWAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 627 TAIWAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 628 TAIWAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 629 TAIWAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 630 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 631 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 632 TAIWAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 633 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 634 TAIWAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 635 TAIWAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 636 TAIWAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 637 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 638 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 639 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 640 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 641 REST OF ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 642 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)

TABLE 643 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 644 SOUTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 645 SOUTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 646 SOUTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 647 SOUTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 648 SOUTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 649 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 650 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 651 SOUTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 652 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 653 SOUTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 654 SOUTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 655 SOUTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 656 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 657 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 658 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 659 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 660 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 661 BRAZIL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 662 BRAZIL AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 663 BRAZIL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 664 BRAZIL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 665 BRAZIL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 666 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 667 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 668 BRAZIL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 669 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 670 BRAZIL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 671 BRAZIL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 672 BRAZIL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 673 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 674 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 675 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 676 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 677 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 678 ARGENTINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 679 ARGENTINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 680 ARGENTINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 681 ARGENTINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 682 ARGENTINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 683 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)

TABLE 684 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)

TABLE 685 ARGENTINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 686 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 687 ARGENTINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 688 ARGENTINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 689 ARGENTINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)

TABLE 690 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)

TABLE 691 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)

TABLE 692 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)

TABLE 693 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)

TABLE 694 REST OF SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 695 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031(USD THOUSAND)

TABLE 696 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 697 MIDDLE EAST AND AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)

TABLE 698 MIDDLE EAST AND AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 699 MIDDLE EAST AND AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 700 MIDDLE EAST AND AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 701 MIDDLE EAST AND AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 702 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 703 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 704 MIDDLE EAST AND AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 705 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 706 MIDDLE EAST AND AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 707 MIDDLE EAST AND AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 708 MIDDLE EAST AND AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 709 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 710 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 711 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 712 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 713 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 714 SOUTH AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 715 SOUTH AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 716 SOUTH AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 717 SOUTH AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 718 SOUTH AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 719 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 720 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 721 SOUTH AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 722 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 723 SOUTH AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 724 SOUTH AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 725 SOUTH AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 726 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 727 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 728 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 729 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 730 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 731 SAUDI ARABIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 732 SAUDI ARABIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 733 SAUDI ARABIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 734 SAUDI ARABIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 735 SAUDI ARABIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 736 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 737 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 738 SAUDI ARABIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 739 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 740 SAUDI ARABIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 741 SAUDI ARABIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 742 SAUDI ARABIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 743 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 744 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 745 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 746 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 747 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 748 BAHRAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 749 BAHRAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 750 BAHRAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 751 BAHRAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 752 BAHRAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 753 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 754 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 755 BAHRAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 756 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 757 BAHRAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 758 BAHRAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 759 BAHRAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 760 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 761 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 762 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 763 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 764 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 765 UNITED ARAB EMIRATES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 766 UNITED ARAB EMIRATES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 767 UNITED ARAB EMIRATES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 768 UNITED ARAB EMIRATES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 769 UNITED ARAB EMIRATES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 770 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 771 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 772 UNITED ARAB EMIRATES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 773 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 774 UNITED ARAB EMIRATES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 775 UNITED ARAB EMIRATES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 776 UNITED ARAB EMIRATES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 777 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 778 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 779 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 780 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 781 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 782 KUWAIT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 783 KUWAIT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 784 KUWAIT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 785 KUWAIT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 786 KUWAIT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 787 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 788 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 789 KUWAIT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 790 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 791 KUWAIT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 792 KUWAIT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 793 KUWAIT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 794 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 795 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 796 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 797 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 798 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 799 QATAR AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 800 QATAR AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 801 QATAR PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 802 QATAR SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 803 QATAR LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 804 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 805 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 806 QATAR LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 807 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 808 QATAR PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 809 QATAR MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 810 QATAR UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 811 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 812 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 813 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 814 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 815 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 816 EGYPT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 817 EGYPT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 818 EGYPT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 819 EGYPT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 820 EGYPT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 821 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 822 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 823 EGYPT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 824 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 825 EGYPT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 826 EGYPT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 827 EGYPT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 828 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 829 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 830 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 831 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 832 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 833 OMAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 834 OMAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 835 OMAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 836 OMAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 837 OMAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 838 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)

TABLE 839 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)

TABLE 840 OMAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

TABLE 841 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 842 OMAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 843 OMAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 844 OMAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)

TABLE 845 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)

TABLE 846 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)

TABLE 847 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)

TABLE 848 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)

TABLE 849 REST OF MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)

Liste des figures

FIGURE 1 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION

FIGURE 2 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION

FIGURE 9 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE THE FASTEST-GROWING REGION WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2031

FIGURE 10 A RISE IN THE INCIDENCE OF INBORN ERRORS OF METABOLISM AND AN INCREASE IN THE NUMBER OF THE NEWBORN SCREENING PROCEDURES ARE EXPECTED TO DRIVE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2031

FIGURE 11 THE AMINO ACID SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET IN 2023 AND 2031

FIGURE 12 ASIA-PACIFIC IS THE MAXIMUM GROWING REGION FOR THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2031

FIGURE 13 EPIDEMIOLOGY

FIGURE 14 PORTER’S FIVE FORCES

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET

FIGURE 16 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, 2022

FIGURE 17 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, 2022

FIGURE 18 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, 2022

FIGURE 19 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORMS, 2022

FIGURE 20 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, 2022

FIGURE 21 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 22 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2022)

FIGURE 23 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2022)

FIGURE 24 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET : SNAPSHOT (2022)

FIGURE 25 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)

FIGURE 26 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)

FIGURE 27 MIDDLE EAST AND AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)

FIGURE 28 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)

FIGURE 29 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)

FIGURE 30 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)

FIGURE 31 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The market is segmented based on Global Medical Foods for Inborn Errors of Metabolism Market, By Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, and Others), Diseases (Phenylketonuria (PKU), Ryrosinemia Types I And II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Academia, Disorders Of Leucine Metabolism, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Forms (Powder, Liquid, Tablets , Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Drugs Store, and Others) - Industry Trends and Forecast to 2031. .
The Global Medical Foods For Inborn Errors Of Metabolism Market size was valued at USD 2477.81 USD Million in 2023.
The Global Medical Foods For Inborn Errors Of Metabolism Market is projected to grow at a CAGR of 14.1% during the forecast period of 2024 to 2031.
The major players operating in the market include Nutricia, Abbott, Baxter, Nestlé Health Science, Meiji Holdings Co., Ltd., Hexagon Nutrition Ltd, Kate Farms, Primus Pharmaceuticals, inc., Promin, Ajinomoto Cambrooke, Inc., Galen Limited, Piam Farmaceutici S.P.A., Orpharma Pty Ltd., PKU-Mdmil.com, B. Braun SE, Pristine Organics Pvt Ltd., Mead Johnson & Company, LLC., EBM Medical, Biovencer Healthcare Pvt Ltd, and Solace Nutrition, among others.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Poland, Finland, Denmark, Sweden, Norway, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, New Zealand, Vietnam, Philippines, Taiwan, rest of Asia-Pacific Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, Bahrain, U.A.E., Kuwait, Qatar, Egypt, Oman, and rest of Middle East and Africa.